Curio Digital Therapeutics Inc. Secures $10 Million in Funding to Revolutionize Women's Healthcare with Technology

Curio Digital Therapeutics Inc. is excited to announce a significant achievement in its growth journey, securing $10 million in funding to further advance its mission of revolutionizing women's healthcare. With a strong focus on digital therapeutics and neurobehavioral interventions, Curio is dedicated to addressing the full spectrum of women's health, from puberty through menopause. This latest infusion of capital will be instrumental in enhancing the company’s evidence-based solutions that seamlessly integrate technology with empathy, serving as a supportive "partner in your pocket" for women globally. The funding will specifically bolster Curio’s innovative programs such as MamaLift and Fertilift, which specifically target critical areas within maternal mental health, including postpartum depression. By emphasizing proactive identification and scalable solutions, Curio aims not only to improve health outcomes but also to contribute to substantial cost savings for healthcare systems. The company's unique positioning within the behavioral health continuum uniquely equips it to deliver exceptional results, and this funding will accelerate ongoing innovations, ensuring that Curio remains at the forefront of women's healthcare. As the healthcare landscape continues to evolve, Curio Digital Therapeutics is committed to fostering a supportive environment for women, empowering them through technology-driven solutions that prioritize their mental and emotional well-being. This funding is not just a milestone for Curio; it represents a broader commitment to transforming how women access and experience healthcare.